UnitedHealth Group Files 8-K/A Amendment

TL;DR

UNH filed an amendment to a prior 8-K. Check the details.

AI Summary

UnitedHealth Group Inc. filed an amendment (8-K/A) on September 9, 2025, to a report originally filed on September 8, 2025. This amendment pertains to a Regulation FD Disclosure, with the earliest event reported as September 8, 2025. The filing does not contain specific financial figures or new material events beyond the amendment itself.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to information previously disclosed by UnitedHealth Group. Investors should review the amendment to understand the updated details.

Risk Assessment

Risk Level: low — The filing is an amendment to a previous report and does not introduce new material financial events or risks.

Key Players & Entities

• UNITEDHEALTH GROUP INC (company) — Registrant
• September 8, 2025 (date) — Date of earliest event reported
• September 9, 2025 (date) — Date of report (Amendment filing date)

FAQ

Filing Documents

• unh-20250908.htm (8-K/A) — 35KB
• 0000731766-25-000247.txt ( ) — 196KB
• unh-20250908.xsd (EX-101.SCH) — 3KB
• unh-20250908_def.xml (EX-101.DEF) — 16KB
• unh-20250908_lab.xml (EX-101.LAB) — 29KB
• unh-20250908_pre.xml (EX-101.PRE) — 17KB
• unh-20250908_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Senior leaders from UnitedHealth Group Incorporated (the "Company") will be meeting with investors and analysts between September 8, 2025 and September 10, 2025, during which the Company intends to: Reaffirm our adjusted 2025 earnings per share expectations previously disclosed by the Company on July 29, 2025. This outlook incorporates closing the acquisition of Amedisys in August 2025, which is expected to be dilutive to adjusted earnings per share due to financing costs and the integration related investments. Discuss preliminary Centers for Medicare & Medicaid Services (CMS) Medicare Advantage star ratings for Star Year 2026 / Payment Year 2027. While the data is not final and still under evaluation, based on our preliminary review of the information, we estimate we will have approximately 78% of our membership in 4 star or higher plans, which is consistent with our expectations and in line with historical performance. The meetings may also include discussion of the Company's strategy, market positions and recent results, as previously disclosed. The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.

Forward-Looking Statements

Forward-Looking Statements The statements, estimates, projections, guidance or outlook contained in this report include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities laws. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; the DOJ's legal actions concerning our participation in the Medicare program; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations; increases in costs and other liabilities asso

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 9, 2025 UNITEDHEALTH GROUP INCORPORATED By: /s/ Kuai H. Leong Kuai H. Leong Senior Deputy General Counsel and Deputy Corporate Secretary

View Full Filing

View this 8-K/A filing on SEC EDGAR